- Florian Gerard-Mercier joined Andera partners in April 2021 as an Analyst in the Andera Life Sciences team, dedicated to investing in life sciences. He is now an Investment Manager.
- Florian has more than ten years experience in academic research –including six years in Tokyo, Japan–, at CNRS and CEA in France, and in RIKEN Center for Brain Science. For his PhD in Neuroscience, he worked on sensory systems and on higher cognitive functions. Returned to France to become a tenured researcher at CEA, he researched early diagnosis biomarkers and advanced therapies for neurodegenerative diseases.
- His PhD was co-sponsored between Saitama University, Japan, and the École Polytechnique, Palaiseau, France. He has a Master’s in life sciences from Paris Diderot University, and is also an engineer of the École Polytechnique.
- A French native, Florian speaks fluent English and Japanese, as well as some German.
10 years of academic research
Investments of Florian
Ariceum
Novel medicines for systemic targeted radiotherapy to visualize and treat cancer
BioVentrix
Development of clinical solutions for the treatment of patients suffering from heart failure
FIRE 1
Technology for heart failure patients
Targed
Biotechnology company focused on developing improved treatments for thrombotic diseases
The team andera Life Sciences
Raphaël Wisniewski
Partner
Olivier Litzka
Partner
Sofia Ioannidou
Partner
Jan Van den Bossche
Partner
Gilles Nobécourt
Partner
Aneta Sottil
Partner
Mathieu Piéronne
Director
Yuexin Yu
Director
Natali Romero Barrios
Investment Manager
Yanis Feraoun
Analyst
Elyes Chouaieb
Investment Director
Loan Hoang-Sayag
Venture Partner
Florian Gerard-Mercier
Investment Manager
Emmanuelle Payet
Middle Office
Thierry Hercend
Venture Partner
Raymond W. Cohen
Venture Advisor
Vanessa Bonvalot
Executive Assistant